✦ LIBER ✦

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials

✍ Scribed by Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Veronica Lonati; Sandro Barni

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 371 KB
Volume: 138
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-011-1072-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erythropoiesis-stimulating agents in the

Erythropoiesis-stimulating agents in the treatment of anemia in myelodysplastic syndromes: a meta-analysis

✍ Victor Moyo; Patrick Lefebvre; Mei Sheng Duh; Behin Yektashenas; Suneel Mundle 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 209 KB

Outcomes of erythropoiesis-stimulating a

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia

✍ Chris L. Pashos; Kay Larholt; Kimberly A. Fraser; R. Scott McKenzie; Mekré Senbe 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 211 KB

Bevacizumab in metastatic breast cancer:

Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials

✍ A. Valachis; N. P. Polyzos; N. Α. Patsopoulos; V. Georgoulias; D. Mavroudis; D. 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 360 KB

Fluoroquinolone prophylaxis in patients

Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials

✍ H. Imran; I. M. Tleyjeh; C. A. S. Arndt; L. M. Baddour; P. J. Erwin; C. Tsigreli 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 379 KB

The addition of tocilizumab to DMARD the

The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials

✍ Mao Mao An; Zui Zou; Hui Shen; Jun Dong Zhang; Yong Bing Cao; Yuan Ying Jiang 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 387 KB

Risk of bleeding complications with anti

Risk of bleeding complications with antiplatelet agents: Meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials

✍ Victor L. Serebruany; Alex I. Malinin; Roswith M. Eisert; David C. Sane 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract Antiplatelet therapy has been the focus of extensive clinical investigations over the last two decades. A variety of agents and regimens have been advanced for the prevention and treatment of vascular disease. Despite the proven life‐saving clinical benefits of inhibiting platelets, thi